What GW PHARMACEUTICALS PLC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Giacobello Scott M. | Chief Financial Officer | May 05 | Disposition to Issuer · D | −165,108 | — | — | 0 |
| Secor Alicia | Director | May 05 | Disposition to Issuer · D | −10,584 | — | — | 0 |
| Mackey Catherine J | Director | May 05 | Disposition to Issuer · D | −10,536 | — | — | 0 |
| Gover Justin D. | Chief Executive Officer | May 05 | Disposition to Issuer · D | −1,867,308 | — | — | 0 |
| Gover Justin D. | Chief Executive Officer | May 05 | Disposition to Issuer · D | −456,048 | — | — | 0 |
| Gover Justin D. | Chief Executive Officer | May 05 | Disposition to Issuer · D | −222,773 | — | — | 0 |
| Guy Geoffrey W Dr | Executive Chairman | May 05 | Disposition to Issuer · D | −103,925 | — | — | 0 |
| Guy Geoffrey W Dr | Executive Chairman | May 05 | Disposition to Issuer · D | −25,000 | — | — | 0 |
| Guy Geoffrey W Dr | Executive Chairman | May 05 | Disposition to Issuer · D | −4,781,521 | — | — | 0 |
| Noble James | Director | May 05 | Disposition to Issuer · D | −27,492 | — | — | 0 |
| Snyder Douglas B. | Chief Legal Officer | May 05 | Disposition to Issuer · D | −61,848 | — | — | 0 |
| Tovey Christopher J. | Chief Operating Officer | May 05 | Disposition to Issuer · D | −2,496 | — | — | 0 |
| Brown Cabot | Director | May 05 | Disposition to Issuer · D | −7,200 | — | — | 0 |
| Knappertz Volker | Chief Medical Officer | May 05 | Disposition to Issuer · D | −92,412 | — | — | 0 |
| Cline Darren S | U.S. Chief Commercial Officer | May 05 | Disposition to Issuer · D | −5,556 | — | — | 0 |
| Snyder Douglas B. | Chief Legal Officer | Mar 26 | Open-market sale · S | −8,400 | $18.12 | −$152K | 61,848 |
| Knappertz Volker | Director | Mar 26 | Open-market sale · S | −3,060 | $18.10 | −$55.4K | 92,412 |
| Gover Justin D. | Chief Executive Officer | Mar 19 | Gift · G | −276,000 | — | — | 1,867,308 |
| Brown Cabot | Director | Mar 18 | Open-market sale · S | −4,020 | $17.95 | −$72.2K | 7,200 |
| Giacobello Scott M. | Chief Financial Officer | Mar 01 | Withheld — tax / exercise cost · F | −3,300 | $17.85 | −$58.9K | 165,108 |
Loading...